Harini Krishnan

1.1k total citations
17 papers, 431 citations indexed

About

Harini Krishnan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Harini Krishnan has authored 17 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Harini Krishnan's work include Lymphatic System and Diseases (8 papers), Galectins and Cancer Biology (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Harini Krishnan is often cited by papers focused on Lymphatic System and Diseases (8 papers), Galectins and Cancer Biology (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Harini Krishnan collaborates with scholars based in United States, United Kingdom and Sweden. Harini Krishnan's co-authors include Gary S. Goldberg, W. Todd Miller, Edward P. Retzbach, Yongquan Shen, Julie Rayes, Tomoyuki Miyashita, Lasse D. Jensen, Genichiro Ishii, Ai Takemoto and Kazue Yoneda and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Harini Krishnan

17 papers receiving 427 citations

Peers

Harini Krishnan

ONCOL

IMMUN

SURGE

PRM

Lars Tögel Germany

Guylène Bertrand France

Jake A. Kloeber United States

Sumihito Togi Japan

Guo‐Kang Fan China

Gabrielle Carvalho France

Valentina Karin‐Kujundžić Croatia

Ruth Asher United Kingdom

Kelly DuPree United States

L Lauerová Czechia

Lars Tögel Germany

Harini Krishnan

381 ×1.8

142 ×0.7

ONCOL

79 ×0.9

IMMUN

73 ×1.6

SURGE

67 ×1.8

PRM

Citations per year, relative to Harini Krishnan Harini Krishnan (= 1×) peers Lars Tögel

Countries citing papers authored by Harini Krishnan

Since Specialization

Citations

This map shows the geographic impact of Harini Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harini Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harini Krishnan more than expected).

Fields of papers citing papers by Harini Krishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harini Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harini Krishnan. The network helps show where Harini Krishnan may publish in the future.

Co-authorship network of co-authors of Harini Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Harini Krishnan. A scholar is included among the top collaborators of Harini Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harini Krishnan. Harini Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Krishnan, Harini, Sultan Ahmed, Stevan R. Hubbard, & W. Todd Miller. (2024). Catalytic activities of wild‐type C. elegansDAF‐2 kinase and dauer‐associated mutants. FEBS Journal. 291(24). 5435–5454. 1 indexed citations

Krishnan, Harini, Sultan Ahmed, Stevan R. Hubbard, & W. Todd Miller. (2023). Biochemical characterization of the Drosophila insulin receptor kinase and longevity‐associated mutants. The FASEB Journal. 38(1). e23355–e23355. 1 indexed citations

Retzbach, Edward P., et al.. (2022). Independent effects of Src kinase and podoplanin on anchorage independent cell growth and migration. Molecular Carcinogenesis. 61(7). 677–689. 4 indexed citations

Retzbach, Edward P., Premalatha Balachandran, Harini Krishnan, et al.. (2021). Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression. Experimental Cell Research. 403(1). 112594–112594. 16 indexed citations

Krishnan, Harini, W. Todd Miller, Francisco J. Blanco, & Gary S. Goldberg. (2018). Src and podoplanin forge a path to destruction. Drug Discovery Today. 24(1). 241–249. 17 indexed citations

Krishnan, Harini, Julie Rayes, Tomoyuki Miyashita, et al.. (2018). Podoplanin: An emerging cancer biomarker and therapeutic target. Cancer Science. 109(5). 1292–1299. 135 indexed citations

Krishnan, Harini, et al.. (2018). Estrogen Receptor α- and β-Interacting Proteins Contain Consensus Secondary Structures: An Insilico Study.. PubMed. 25(1). 1–10. 3 indexed citations

Retzbach, Edward P., Harini Krishnan, Yongquan Shen, et al.. (2016). Abstract 1215: Utilization of podoplanin as a chemotherapeutic target for oral squamous cell carcinoma. Cancer Research. 76(14_Supplement). 1215–1215. 1 indexed citations

Krishnan, Harini, Edward P. Retzbach, María I. Ramirez, et al.. (2015). PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility. Experimental Cell Research. 335(1). 115–122. 23 indexed citations

10.

Krishnan, Harini, Yongquan Shen, Min Han, et al.. (2015). Abstract 4375: Podoplanin (PDPN): novel biomarker and chemotherapeutic target. Cancer Research. 75(15_Supplement). 4375–4375. 1 indexed citations

11.

Kolar, Kushal, Moises Freitas‐Andrade, John F. Bechberger, et al.. (2014). Podoplanin. Journal of Neuropathology & Experimental Neurology. 74(1). 64–74. 41 indexed citations

12.

Krishnan, Harini, Yongquan Shen, Mary C. Williams, et al.. (2013). Serines in the Intracellular Tail of Podoplanin (PDPN) Regulate Cell Motility. Journal of Biological Chemistry. 288(17). 12215–12221. 53 indexed citations

13.

Krishnan, Harini, W. Todd Miller, & Gary S. Goldberg. (2012). Src Points the Way to Biomarkers and Chemotherapeutic Targets. Genes & Cancer. 3(5-6). 426–435. 17 indexed citations

14.

Krishnan, Harini, Yongquan Shen, Nimish K. Acharya, et al.. (2012). Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration. PLoS ONE. 7(7). e41845–e41845. 59 indexed citations

15.

Krishnan, Harini, Trudy F. Ramlall, Yongquan Shen, et al.. (2010). Src activates Abl to augment Robo1 expression in order to promote tumor cell migration. Oncotarget. 1(3). 198–209. 20 indexed citations

16.

Phillips, David R., et al.. (2008). First UK report of successful treatment of Mycobacterium simiae and immune reconstitution inflammatory syndrome in an HIV-seropositive patient. Sexually Transmitted Infections. 84(4). 271–272. 13 indexed citations

17.

Adwani, Asha, et al.. (2005). Tattoo pigment in an axillary lymph node simulating metastatic malignant melanoma. PubMed. 2(1). 28–28. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact